Products

ABMEDICA

DB2C was founded in 1992 as a manufacturer and supplier of premium reusable surgical instruments for laparoscopy. The engineering and the quality of the creative products position DB2C as a leading supplier in the French surgery market.

abmedica acquires DB2C in 2009 and expands its activities in the distribution of devices for highly innovative medical devices for laparoscopy and endovascular treatments.

DB2C / abmedica specializes in the fields of laparoscopic surgery, cardiac surgery and interventional neuroradiology.

***In regulatory registration process

BAXTER - Advanced Surgery

Baxter's portfolio of products and programs are foundational to the cadence of surgery, just as surgeons, nurses, and administrators are essential to the art of healing. Clinically-proven products allow surgical teams freedom to innovate and think creatively without restraint in the operating room. Best-in-class programs provide a holistic approach to optimizing patient care.

DORNIER

With world's bestselling lithotripter and Europe’s market-leading laser Solvo, Dornier MedTech, headquartered in Munich, Germany, is a medical device company known for its pioneering technologies and revolutionary therapies in urology. Thanks to its deep-rooted spirit of entrepreneurship, excellence and innovation, Dornier thrives while developing some of the highest quality urology products on the market today.

LEXION

LEXION Medical is a world leader in the design and manufacturing of advanced technologies for gas conditioning in minimally invasive surgical procedures. Our goal is to provide innovative technologies that help patients return to their normal, productive lives faster. Appropriately conditioning the gas before it enters the body and when it leaves the patient can dramatically help patients, surgeons, and make operating rooms more efficient with improved clinical outcomes.

NUVASIVE

NuVasive® is one of the fastest growing, comprehensive spine companies in the world. NuVasive is committed to providing surgeons a portfolio that minimizes disruption and delivers the best possible patient outcomes, including the industry leading XLIF® procedure.

SPINEVISION

SpineVision® is a privately-owned integrated spinal technology company focused on the development and marketing of implants and instrumentation for spinal treatment.

Since its foundation in 1999, the company has designed innovative products which offer key advantages to surgeons and benefits to patients. SpineVision’s current products offer solutions for approximately 90% of spinal pathologies i.e. lumbar degenerative disc diseases, deformities, cervical disorders, trauma and tumors. With its new generation products Flex+2 and LUMIS SpineVision® is the only manufacturer offering a dynamic stabilization system which can be used in a percutaneous approach.

The Company is headquartered in Antony (south of Paris), France, and has subsidiaries in the USA, Italy, Belgium and UK.

LIVSMED

LIVSMED is a medical device company established in 2011. Their goal and vision are to create unique products that will lead the paradigm of the global medical device industry. ArtiSential has been attracting worldwide attention for its revolutionary capabilities that conventional laparoscopy cannot provide. From 2018, we have grown rapidly in the surgical market and strive to provide articulation to new areas of the globe.

INTOCARE

Intocare Medical Technology Co., Ltd, founded in 2015, is a Chinese high-tech corporation focusing on surgical instruments.

Excellent product comes from the profound insight into demand and constant innovation. “Insight and Innovation to Caring”- this is the meaning of Intocare.

Intocare is currently located in Nanopolis Suzhou, Suzhou Singapore Industrial Park. It is an industrial integrated community, in which major R&D engineering platform, high-end innovation team, industrial development service institution and promotive organization for international industry are located.

MEDASENSE

Medasense is spearheading pain management to achieve optimized and personalized care with improved outcomes.

While pain is a major clinical, social and economic problem, affecting quality of life for hundreds of millions of people globally, measurement of pain has remained subjective. Consequently, pain care is not tailored to patients’ specific needs, opioid addiction has become an epidemic, and the direct costs of pain-related healthcare are soaring.

Addressing this problem, Medasense’s NOL® technology is enabling clinicians to personalize pain management, optimize treatment and avoid overmedication with an innovative noninvasive sensor platform and AI technology.